Tarsus Pharmaceuticals, Inc. (TARS)


Stock Price Forecast

April 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Tarsus Pharmaceuticals, Inc. chart...

About the Company

We do not have any company description for Tarsus Pharmaceuticals, Inc. at the moment.

Exchange

Nasdaq

$11M

Total Revenue

104

Employees

$1B

Market Capitalization

-7.25

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $TARS News

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon

12h ago, source:

IRVINE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- . (NASDAQ: TARS), whose mission is to focus on unmet needs and apply ...

Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%

4d ago, source:

Insiders who bought Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) stock lover the last 12 months are probably not ...

OC Drugmakers Cut Headcounts, Close Offices

1d ago, source: Orange County Business Journal

The Business Journal’s annual listing of the largest local players in the pharmaceutical industry shows a sector that remains ...

Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why

21d ago, source: Hosted on MSN

Investors might want to bet on Tarsus Pharmaceuticals, Inc. (TARS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

9 Best Biotech ETFs for 2024

4d ago, source: GOBankingRates on MSN

Biotechnology uses living organisms to develop new medicines and technologies that benefit both environmental and social ...

Global Atherosclerosis Industry is expected to reach US$ 59,514.3 Million, growing at a consistent CAGR of 2.8% | FMI

9h ago, source: Future Market Insights

The Global Atherosclerosis Industry is on track for significant expansion, with a projected Compound Annual Growth Rate (CAGR ...

Pharmaceutical Lactose Market Momentum: Advancing Towards US$ 392.3 Million by 2033, Averaging 5.8% CAGR

20h ago, source: Future Market Insights

According to Future Market Insights’ latest analysis, the global pharmaceutical lactose market size is expected to reach US$ 222.6 million in 2023 and further expand at 5.8% CAGR throughout the ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Pfizer (PFE) and Cardinal Health (CAH)

15h ago, source:

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Addus Homecare (ADUS – Research Report), Pfizer (PFE – ...

Analysts Are Bullish on Top Healthcare Stocks: Thermo Fisher (TMO), Intra-Cellular Therapies (ITCI)

4d ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Thermo Fisher (TMO – Research Report) and ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...